Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
[33, 34, 35, 36] Mechanism: Typically pre-renal, occurring in the setting of volume depletion from GI losses (nausea, vomiting, diarrhea, reduced oral intake) More frequently seen at higher, obesity-level doses Although generally reno-protective long term, post-marketing data describe acute rises in creatinine following days to weeks of significant GI symptoms Risk factors: Underlying chronic kidney disease Concomitant use of ACE inhibitors, ARBs, diuretics, or SGLT2 inhibitors ED Management: IV fluids Hold GLP-1 and contributing medications Usually reversible with supportive care Future Directions GLP-1 receptor agonists are rapidly evolving beyond their original indications in diabetes and obesity
The multidisciplinary team of GI providers, gut-brain specialists, and registered dietitians at Oshi Health can offer a tailored treatment plan to help you implement the lifestyle and behavioral adjustments needed to reduce GI side effects associated with GLP-1 drugs
Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease
Regeneron Pharmaceuticals Sector: Muscle-preserving antibody combinations and GLP-1 therapy for obesity HQ: Tarrytown, NY Year Founded: 1988 Origin Story: Founded in 1988 by Leonard Schleifer, MD, PhD, a neurologist and assistant professor at Cornell University Medical College on the premise that drug discovery could be industrialized through proprietary antibody-generation technology
Pendulum GLP-1 Probiotic $75.00 Pendulum medical-grade dietary supplements rebalance your gut microbiome and support overall digestive health
US$ 20.58
US$ 24.33
US$ 21.53
US$ 20.46
US$ 21.47
US$ 28.39
US$ 20.03
US$ 28.87
US$ 28.33
US$ 26.86
US$ 21.99
US$ 20.59
